4-(2-Furyl)-2-morpholinyl-1-methyl-6-oxo-1,6-dihydro-pyrimidine-5-carbonitrile

ID: ALA2413099

PubChem CID: 45028920

Max Phase: Preclinical

Molecular Formula: C14H14N4O3

Molecular Weight: 286.29

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cn1c(N2CCOCC2)nc(-c2ccco2)c(C#N)c1=O

Standard InChI:  InChI=1S/C14H14N4O3/c1-17-13(19)10(9-15)12(11-3-2-6-21-11)16-14(17)18-4-7-20-8-5-18/h2-3,6H,4-5,7-8H2,1H3

Standard InChI Key:  DDBHHWPHROAIOH-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 21 23  0  0  0  0  0  0  0  0999 V2000
    4.1386  -11.4469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1386  -12.2719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8531  -12.6844    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5675  -12.2719    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5675  -11.4469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8531  -11.0344    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8531  -10.2094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4241  -12.6844    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4241  -11.0344    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8531  -13.5094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7096  -13.0969    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2820  -11.0344    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.9965  -11.4469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7109  -11.0344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7109  -10.2094    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.9965   -9.7969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2820  -10.2094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1856  -13.9943    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.4406  -14.7789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2656  -14.7789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5205  -13.9943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  6  1  1  0
  6  7  1  0
  2  8  1  0
  1  9  2  0
  3 10  1  0
  8 11  3  0
  5 12  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  1  0
 17 12  1  0
 10 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 10  2  0
M  END

Associated Targets(Human)

UACC-257 (46019 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OVCAR-8 (47708 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Candida albicans (78123 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Shigella flexneri (1836 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pseudomonas aeruginosa (123386 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 286.29Molecular Weight (Monoisotopic): 286.1066AlogP: 0.75#Rotatable Bonds: 2
Polar Surface Area: 84.29Molecular Species: NEUTRALHBA: 7HBD:
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 1.17CX LogP: -0.07CX LogD: -0.07
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.81Np Likeness Score: -1.90

References

1. Fargualy AM, Habib NS, Ismail KA, Hassan AM, Sarg MT..  (2013)  Synthesis, biological evaluation and molecular docking studies of some pyrimidine derivatives.,  66  [PMID:23811090] [10.1016/j.ejmech.2013.05.028]

Source